as on
| Source : NSE
as on August 20, 2025 at 4:01 PM IST
Day's Low
Day's High
4.15%
Downside
6.80%
Upside
52 Week's Low
52 Week's High
38.42%
Downside
38.04%
Upside
Market Stats | |
Previous Close | ₹1,946.60 |
Open | ₹1,956.40 |
Volume | 43.26K |
Upper Circuit | ₹2,335.90 |
Lower Circuit | ₹1,557.30 |
Day's Low | ₹1,934.6 |
Day's High | ₹2,155.7 |
52 Week Low | ₹1,242.95 |
52 Week High | ₹2,786.1 |
Returns % | |
1 Month Return | + 2.49 % |
3 Month Return | + 9.02 % |
1 Year Return | -20.02 % |
3 Year Return | -5.52 % |
5 Year Return | + 31.4 % |
Check Hester Biosciences Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,655.95 Cr
Return on Equity (ROE)
9.77
PE Ratio (TTM)
42.86
Return on capital employed (ROCE)
9.47
Industry PE ratio
43.53
Beta (LTM)
0.45
P/B Ratio
3.15
Dividend Yield
0.56
PEG Ratio
2.18
Quarterly Earnings Growth YOY
130.97
EPS (TTM)
33.89
Sector
Pharmaceuticals
Book Value
369.41
Technical Analysis
Bullish
View Technical Analysis
Track how Hester Biosciences Ltd P/E has moved over time to understand its valuation trends.
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Today (42.86x)
August 19, 2025
Industry (43.53x)
August 19, 2025
Highest (124.52x)
July 26, 2024
Today’s Price to Earnings Ratio: 42.86x
Get share price movements and forecasts by analysts on Hester Biosciences Ltd.
Excluding Excise Duty and Other Income, represents Net Revenue
Hester Biosciences Ltd revenue growth forecast
Expected growth rate Q1, FY2023:0.94%
Forecast
Actual
Including amortisation and stock based compensations
Hester Biosciences Ltd EPS growth forecast
EPS estimate Q1, FY2023:13.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Hester Biosciences Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Hester Biosciences Ltd.
Hester Biosciences Ltd’s net profit jumped 159.31% since last year same period to ₹16.44Cr in the Q1 2025-2026. On a quarterly growth basis, Hester Biosciences Ltd has generated 1174.42% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Hester Biosciences Ltd has declared dividend of ₹7.00 per share on 09 May 2025 - translating a dividend yield of 0.67%.
Read More about DividendsCheck stock indices that include Hester Biosciences Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Hester Biosciences Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 53.73% | 0.00 | |
Foreign Institutions | 0.04% | ||
Mutual Funds | 0% | 12.50 | |
Retail Investors | 45.73% | 0.78 | |
Others | 0.49% | 2690.34 |
Compare market cap, revenue, PE, and other key metrics of Hester Biosciences Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 1,655.95 | 6.28% | 0.74 | 28 | 311 | |
BUY | 8,013.96 | 10.61% | 0.72 | 3,597 | 4,565 | |
NA | 45.19 | -16.85% | 0.00 | -22 | 104 | |
NA | 714.35 | 63.1% | 0.58 | 13 | 154 | |
NA | 46.99 | 19.79% | 0.50 | 1 | 67 |
Latest news and events in one place to help you make informed investing decisions in Hester Biosciences Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 1.29 Cr → 16.44 Cr (in ₹), with an average increase of 92.2% per quarter
Retail Holding Up
Retail Investor have increased holdings from 45.38% to 45.73% in Jun 2025 quarter
Revenue Rich
Revenue is up for the last 3 quarters, 72.0 Cr → 87.47 Cr (in ₹), with an average increase of 9.2% per quarter
Price Rise
In the last 1 month, HESTERBIO stock has moved up by 2.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 28.7% return, outperforming this stock by 48.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.2% return, outperforming this stock by 144.7%
FII Holding Down
Foreign Institutions have decreased holdings from 0.87% to 0.04% in Jun 2025 quarter
Organisation | Hester Biosciences Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Hester Biosciences Ltd.
Funds | Holdings | Prev. 5M |
---|---|---|
Bandhan BSE Healthcare Index Fund Direct Growth | 0.05% | |
Motilal Oswal BSE 1000 Index Fund Direct Growth | 0% |
Hester Biosciences Ltd share price today stands at ₹2018.4, Open: ₹1956.4, Previous Close: ₹1946.6, High: ₹2155.7, Low: ₹1934.6, 52 Week High: ₹2786.1, 52 Week Low: ₹1242.95 as on .
To buy Hester Biosciences Ltd shares, you need to follow these steps:
Today's traded volume of Hester Biosciences Ltd is 43.26K. Which means that 43.26K shares of Hester Biosciences Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Hester Biosciences Ltd is ₹1,655.95 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Hester Biosciences Ltd’s 52 week high is ₹2786.1 and 52 week low is ₹1242.95. The current share price of Hester Biosciences Ltd is ₹2018.4, which is -27.55% down from its 52 week high and 62.39% up from its 52 week low.